Latest

Rapid viral sequencing information was provided to infection, prevention and control teams in hospitals to discover whether this would allow them to implement control measures more accurately and faster to reduce spread of COVID. The results from this study will be critical to planning what is needed to harness genomic data linked to patient data for controlling hospital outbreaks and managing individual patients.

Data-driven evolutions in healthcare have the potential to transform care for the better, but they can also exacerbate existing health inequalities (Challenging racism in the use of health data, Lancet, 2021). Here, Jacqui Gath shares her thoughts on the importance of data diversity in healthcare research and the steps that can be taken to address inequalities in healthcare.

As a GP working over the course of the pandemic across multiple GP sites, but predominantly in Enfield, I have been quite overwhelmed by the rise in the incidence of patients presenting with worsening of chronic conditions such as diabetes, hypertension and asthma and COPD.

The London Evaluation Cell, established in June 2020, has led to the development of a network that enables collaboration and knowledge sharing that did not previously exist. This enables clinical and academic health leaders to collectively identify and set evaluation priorities, with the aim of rapidly translating knowledge into service provision across the regional care sector.

Network Development Lead Sophie Bulmer shares some of the key insights discussed in a recent webinar about the vaccination programme in London.

Francesca Faravelli is Clinical Director of the North Thames Genomic Medicine Service (GMS) Alliance, hosted by UCLPartners and supported by Imperial College Health Partners. In this blog Francesca considers how our understanding and use of genomics has evolved and explains how the newly launched North Thames GMS Alliance will bring the benefits of genomics to patients.

We are delighted to announce the appointment of Professor Steve Thornton as Interim Managing Director of UCLPartners.

Data and AI expertise at UCLPartners has been highlighted in new report on London as a Hub for Health & Life Sciences innovation, by London & Partners and MedCity

The outstanding work of clinical, academic, and operational staff from across the UCLPartners academic and healthcare community has been recognised in the Queen’s birthday honours.

Daphne Amevenu is Deputy Programme Director for cardiovascular disease (CVD) prevention and proactive care at UCLPartners. Here, Daphne reflects on the importance of involving patients and the public in healthcare design and explains the approach she has taken to ensure patients are influencing the way the UCLPartners’ proactive care programme develops.